Active ingredientLynestrenolCat. No. P-L116-001CAS 52-76-6Family · Pharmaceutical analytical standards
Lynestrenol
A synthetic progestin discovered in the late 1950s, patented in the Netherlands in 1957 and in medical use since 1961; it is used in the contraceptive pill and for menstrual disorders. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?On its own it is inactive: it is a prodrug that the liver converts almost completely into norethisterone. In 1962 it became part of the first Dutch contraceptive pill.
Go to the active ingredient →Active ingredientLynestrenolCat. No. P-L116-001CAS 52-76-6
Pharmacopoeial impurityLynestrenol EP Impurity ACat. No. P-L116-002
Pharmacopoeial impurityLynestrenol EP Impurity BCat. No. P-L116-003CAS 58311-09-4
Pharmacopoeial impurityLynestrenol EP Impurity CCat. No. P-L116-004CAS 5225-38-7No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceLynestrenol CRSEDQM code L0800000Family LynestrenolNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.